New York Senate Bill 6925: Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.

New York · 2025-2026 session

What it does

Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.

Latest action

REFERRED TO INSURANCE (2025-03-27)

See how S 6925 affects you on CapitolKey

Browse more bills · CapitolKey home